157 related articles for article (PubMed ID: 26536456)
81. Nrf2 Modulation in Breast Cancer.
Ghareghomi S; Habibi-Rezaei M; Arese M; Saso L; Moosavi-Movahedi AA
Biomedicines; 2022 Oct; 10(10):. PubMed ID: 36289931
[TBL] [Abstract][Full Text] [Related]
82. A Splice Variant of NCOR2, BQ323636.1, Confers Chemoresistance in Breast Cancer by Altering the Activity of NRF2.
Leung MH; Tsoi H; Gong C; Man EP; Zona S; Yao S; Lam EW; Khoo US
Cancers (Basel); 2020 Feb; 12(3):. PubMed ID: 32110852
[TBL] [Abstract][Full Text] [Related]
83. Phase I study of topical epigallocatechin-3-gallate (EGCG) in patients with breast cancer receiving adjuvant radiotherapy.
Zhao H; Zhu W; Jia L; Sun X; Chen G; Zhao X; Li X; Meng X; Kong L; Xing L; Yu J
Br J Radiol; 2016; 89(1058):20150665. PubMed ID: 26607642
[TBL] [Abstract][Full Text] [Related]
84. Nuclear factor, erythroid 2-like 2-associated molecular signature predicts lung cancer survival.
Qian Z; Zhou T; Gurguis CI; Xu X; Wen Q; Lv J; Fang F; Hecker L; Cress AE; Natarajan V; Jacobson JR; Zhang DD; Garcia JG; Wang T
Sci Rep; 2015 Nov; 5():16889. PubMed ID: 26596768
[TBL] [Abstract][Full Text] [Related]
85. Nrf2 Signaling and the Slowed Aging Phenotype: Evidence from Long-Lived Models.
Bruns DR; Drake JC; Biela LM; Peelor FF; Miller BF; Hamilton KL
Oxid Med Cell Longev; 2015; 2015():732596. PubMed ID: 26583062
[TBL] [Abstract][Full Text] [Related]
86. NRF2 Regulates PINK1 Expression under Oxidative Stress Conditions.
Murata H; Takamatsu H; Liu S; Kataoka K; Huh NH; Sakaguchi M
PLoS One; 2015; 10(11):e0142438. PubMed ID: 26555609
[TBL] [Abstract][Full Text] [Related]
87. Nrf2 as a master regulator of tissue damage control and disease tolerance to infection.
Soares MP; Ribeiro AM
Biochem Soc Trans; 2015 Aug; 43(4):663-8. PubMed ID: 26551709
[TBL] [Abstract][Full Text] [Related]
88. Caveolin-1 regulates cancer cell metabolism via scavenging Nrf2 and suppressing MnSOD-driven glycolysis.
Hart PC; Ratti BA; Mao M; Ansenberger-Fricano K; Shajahan-Haq AN; Tyner AL; Minshall RD; Bonini MG
Oncotarget; 2016 Jan; 7(1):308-22. PubMed ID: 26543228
[TBL] [Abstract][Full Text] [Related]
89. NRF2 Mediates Neuroblastoma Proliferation and Resistance to Retinoic Acid Cytotoxicity in a Model of In Vitro Neuronal Differentiation.
de Miranda Ramos V; Zanotto-Filho A; de Bittencourt Pasquali MA; Klafke K; Gasparotto J; Dunkley P; Gelain DP; Moreira JCF
Mol Neurobiol; 2016 Nov; 53(9):6124-6135. PubMed ID: 26541884
[TBL] [Abstract][Full Text] [Related]
90. Prediagnostic serum glucose and lipids in relation to survival in breast cancer patients: a competing risk analysis.
Wulaningsih W; Vahdaninia M; Rowley M; Holmberg L; Garmo H; Malmstrom H; Lambe M; Hammar N; Walldius G; Jungner I; Coolen AC; Van Hemelrijck M
BMC Cancer; 2015 Nov; 15():913. PubMed ID: 26577580
[TBL] [Abstract][Full Text] [Related]
91. Genetic association analysis of miRNA SNPs implicates MIR145 in breast cancer susceptibility.
Chacon-Cortes D; Smith RA; Haupt LM; Lea RA; Youl PH; Griffiths LR
BMC Med Genet; 2015 Nov; 16():107. PubMed ID: 26577090
[TBL] [Abstract][Full Text] [Related]
92. The Mediator Subunit MED16 Transduces NRF2-Activating Signals into Antioxidant Gene Expression.
Sekine H; Okazaki K; Ota N; Shima H; Katoh Y; Suzuki N; Igarashi K; Ito M; Motohashi H; Yamamoto M
Mol Cell Biol; 2016 Feb; 36(3):407-20. PubMed ID: 26572828
[TBL] [Abstract][Full Text] [Related]
93. Sulforaphane induces Nrf2 target genes and attenuates inflammatory gene expression in microglia from brain of young adult and aged mice.
Townsend BE; Johnson RW
Exp Gerontol; 2016 Jan; 73():42-8. PubMed ID: 26571201
[TBL] [Abstract][Full Text] [Related]
94. Squid ink polysaccharide reduces cyclophosphamide-induced testicular damage via Nrf2/ARE activation pathway in mice.
Le X; Luo P; Gu Y; Tao Y; Liu H
Iran J Basic Med Sci; 2015 Aug; 18(8):827-31. PubMed ID: 26557973
[TBL] [Abstract][Full Text] [Related]
95. High glucose induces renal tubular epithelial injury via Sirt1/NF-kappaB/microR-29/Keap1 signal pathway.
Zhou L; Xu DY; Sha WG; Shen L; Lu GY; Yin X; Wang MJ
J Transl Med; 2015 Nov; 13():352. PubMed ID: 26552447
[TBL] [Abstract][Full Text] [Related]
96. Predictive significance of DNA damage and repair biomarkers in triple-negative breast cancer patients treated with neoadjuvant chemotherapy: An exploratory analysis.
Vici P; Di Benedetto A; Ercolani C; Pizzuti L; Di Lauro L; Sergi D; Sperati F; Terrenato I; Dattilo R; Botti C; Fabi A; Ramieri MT; Mentuccia L; Marinelli C; Iezzi L; Gamucci T; Natoli C; Vitale I; Barba M; Mottolese M; De Maria R; Maugeri-Saccà M
Oncotarget; 2015 Dec; 6(40):42773-80. PubMed ID: 26544894
[TBL] [Abstract][Full Text] [Related]
97. Innovative Delivery and Release Systems for Antioxidants and Other Active Substances in the Treatment of Cancer.
Sezgin-Bayindir Z; Losada-Barreiro S; Fernández-Bravo S; Bravo-Díaz C
Pharmaceuticals (Basel); 2023 Jul; 16(7):. PubMed ID: 37513948
[TBL] [Abstract][Full Text] [Related]
98. The Potential Role of Epigallocatechin-3-Gallate (EGCG) in Breast Cancer Treatment.
Marín V; Burgos V; Pérez R; Maria DA; Pardi P; Paz C
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445915
[TBL] [Abstract][Full Text] [Related]
99. A Review of RRx-001: A Late-Stage Multi-Indication Inhibitor of NLRP3 Activation and Chronic Inflammation.
Jayabalan N; Oronsky B; Cabrales P; Reid T; Caroen S; Johnson AM; Birch NA; O'Sullivan JD; Gordon R
Drugs; 2023 Apr; 83(5):389-402. PubMed ID: 36920652
[TBL] [Abstract][Full Text] [Related]
100. Role of Nrf2 Signaling Cascade in Breast Cancer: Strategies and Treatment.
Kumar H; Kumar RM; Bhattacharjee D; Somanna P; Jain V
Front Pharmacol; 2022; 13():720076. PubMed ID: 35571115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
